News

Bristol Myers Squibb BMY announced a strategic collaboration agreement with BioNTech BNTX for the global co-development and ...
Hong Kong-based Sino Biopharm, which took its stake in LaNova when it participated in the company's $42 million financing ...
Bristol Myers Squibb (BMY) closed at $47.17 in the latest trading session, marking a +1.59% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.32%. At the same ...